SCHEMBL26022322

SCHEMBL26022322

C=C/C(=C\C=C/C)c1ccc(COCCCC(C)CN2C[C@H](O)CC(N=O)[C@@H]2CN=O)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26022369 0.78 UGCG (0.37) —
SCHEMBL26219887 0.74 GBA1 (0.43) —
SCHEMBL25962179 0.72 GBA1 (0.45) —
SCHEMBL25962156 0.70 GBA1 (0.42) —
SCHEMBL25962338 0.69 UGCG (0.45) —
SCHEMBL25962145 0.67 UGCG (0.44) —
SCHEMBL25962370 0.67 UGCG (0.44) —
SCHEMBL25962272 0.65 UGCG (0.40) —
SCHEMBL26022198 0.65 GBA1 (0.42) —
SCHEMBL25962125 0.64 UGCG (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4114826-B1 CRYSTALLINE FORMS OF A PHARMACEUTICAL COMPOUND AZAFAROS B V (NL) 2023-08-23 — — EP disclosed
Send feedback